Table 5.

Univariate analyses for predictive factors of recurrence in stage II CRC patients

Variables	HR$	95%CI	p value
Age (≥ 67 vs. <67)	0.91	0.20–4.05	0.9
Gender (Female vs. Male)	1.33	0.26–6.81	0.73
Pathological T stage (T3/4 vs.1/2)	0.21	0.02–1.85	0.16
Pathology (poor vs. mod/well differentiated)	4.55	0.87–23.93	0.07
Venous invasion (positive vs. negative)	2.72	0.52–14.21	0.24
Lymphatic invasion (positive vs. negative)	0.38	0.09–2.46	0.47
CEA (≥ 5 vs. <5)	1.51	0.25–9.00	0.65
miR-200c in serum (high vs. low)	8.43	1.00–72.96	0.01

CI, Confidence interval; CEA, Carcinoembryonic antigen; mod, moderately;

^$HR, hazard ratio for recurrence in CRC patients